EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H25N5O5 |
| Net Charge | 0 |
| Average Mass | 451.483 |
| Monoisotopic Mass | 451.18557 |
| SMILES | COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC |
| InChI | InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26) |
| InChIKey | RUZYUOTYCVRMRZ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antihyperplasia drug A drug used for the treatment of hyperplasia (increaced cell production within an organ or tissue). alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. vasodilator agent A drug used to cause dilation of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| doxazosin (CHEBI:4708) has role antihyperplasia drug (CHEBI:59844) |
| doxazosin (CHEBI:4708) has role antihypertensive agent (CHEBI:35674) |
| doxazosin (CHEBI:4708) has role antineoplastic agent (CHEBI:35610) |
| doxazosin (CHEBI:4708) has role vasodilator agent (CHEBI:35620) |
| doxazosin (CHEBI:4708) has role α-adrenergic antagonist (CHEBI:37890) |
| doxazosin (CHEBI:4708) is a N-acylpiperazine (CHEBI:46844) |
| doxazosin (CHEBI:4708) is a N-arylpiperazine (CHEBI:46848) |
| doxazosin (CHEBI:4708) is a aromatic amine (CHEBI:33860) |
| doxazosin (CHEBI:4708) is a benzodioxine (CHEBI:64096) |
| doxazosin (CHEBI:4708) is a monocarboxylic acid amide (CHEBI:29347) |
| doxazosin (CHEBI:4708) is a quinazolines (CHEBI:38530) |
| Incoming Relation(s) |
| doxazosin mesylate (CHEBI:4709) has part doxazosin (CHEBI:4708) |
| IUPAC Name |
|---|
| 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine |
| INNs | Source |
|---|---|
| doxazosin | WHO MedNet |
| doxazosina | WHO MedNet |
| doxazosine | WHO MedNet |
| doxazosinum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin | ChemIDplus |
| 1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin | ChemIDplus |
| Doxazosin | KEGG COMPOUND |
| Registry Numbers | Sources |
|---|---|
| Reaxys:731849 | Reaxys |
| CAS:74191-85-8 | KEGG COMPOUND |
| CAS:74191-85-8 | ChemIDplus |
| Citations |
|---|